Clinical Trials Browser

OTHER × sitravatinib × Genitourinary × Clear all

NCT04904302 2026-03-20

Sitravatinib and Nivolumab for the Treatment of Metastatic or Advanced Clear Cell Renal Cell Cancer

Phase 2 Terminated

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT03015740 2024-11-19

Sitravatinib and Nivolumab in Treating Patients With Advanced or Metastatic Kidney Cancer

Phase 1/2 Completed

42 enrolled 14 charts

Carcinoma, Renal Cell